FDA action alert: BMS, TG, Spero and Merck Therapeutics The U.S. Food and Drug Administration has a handful of PDUFA dates over the next two weeks. Read more June 20, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/02/FDA-Investigating-Possible-Death-Risk-Linked-to-TG-Therapeutics-Lymphoma-Drug-BioSpace-2-7-22.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-06-20 09:47:572022-06-20 09:47:57FDA action alert: BMS, TG, Spero and Merck
